Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Eflornithine
Thyroid Gland Papillary Carcinoma
Aminex Therapeutics, Inc.P1/2CCC (48)
Eflornithine
Neoplasm
Aminex Therapeutics, Inc.P1/2CCC (48)
Egfr/Her2 Dual-Target Car-Nk Cells
Head And Neck Squamous Cell Carcinoma
Beijing BiotechP1/2CCC (48)
eik1005
Colorectal Cancer
Eikon TherapeuticsP1/2CCC (48)
eik1005
Gastric Cancer
Eikon TherapeuticsP1/2CCC (48)
eik1005
Gastroesophageal Junction Adenocarcinoma
Eikon TherapeuticsP1/2CCC (48)
Elacestrant
Brain Neoplasm
Stemline Therapeutics, Inc.P1/2CCC (48)
Elacestrant
Central Nervous System Neoplasm
Stemline Therapeutics, Inc.P1/2CCC (48)
Elacestrant
Triple-Positive Breast Carcinoma
NYU Langone HealthP1/2CCC (48)
Eli-002 7P
Colorectal Cancer
Elicio TherapeuticsP1/2CCC (48)
Elimusertib
Alveolar Rhabdomyosarcoma
National Cancer Institute (NCI)P1/2CCC (48)
Elimusertib
Ewing Sarcoma
National Cancer Institute (NCI)P1/2CCC (48)
Elimusertib
Lymphoma
National Cancer Institute (NCI)P1/2CCC (48)
Elironrasib
Colorectal Cancer
Revolution Medicines, Inc.P1/2CCC (48)
Elironrasib
Lung Cancer
Revolution Medicines, Inc.P1/2CCC (48)
Elironrasib
Non-Small Cell Lung Carcinoma
Revolution Medicines, Inc.P1/2CCC (48)
Elisrasib
Cancer
D3 Bio (Wuxi) Co., LtdP1/2CCC (48)
Elranatamab
Myelodysplastic Syndrome
CellCentric Ltd.P1/2CCC (48)
Eltanexor
Acute Myeloid Leukemia
Vanderbilt-Ingram Cancer CenterP1/2CCC (48)
Encorafenib
Pancreatic Ductal Adenocarcinoma
Erasca, Inc.P1/2CCC (48)
Enoxolone
Major Depressive Disorder
Philipps University MarburgP1/2CCC (48)
Entinostat
Human Papilloma Virus Infection
National Cancer Institute (NCI)P1/2CCC (48)
Entinostat
Head And Neck Cancer
National Cancer Institute (NCI)P1/2CCC (48)
Entinostat
Oropharyngeal Carcinoma
National Cancer Institute (NCI)P1/2CCC (48)
Enzalutamide
Esophageal Cancer
Cancer Research UKP1/2CCC (48)
Showing 1151 to 1175 of 6,308 assets
PreviousPage 47 of 253Next